Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9669 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9603 |
High Similarity |
NPD1934 |
Approved |
0.9286 |
High Similarity |
NPD2801 |
Approved |
0.9245 |
High Similarity |
NPD6166 |
Phase 2 |
0.9245 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9245 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9091 |
High Similarity |
NPD4380 |
Phase 2 |
0.9074 |
High Similarity |
NPD7054 |
Approved |
0.9073 |
High Similarity |
NPD1511 |
Approved |
0.9018 |
High Similarity |
NPD7074 |
Phase 3 |
0.9018 |
High Similarity |
NPD7472 |
Approved |
0.8954 |
High Similarity |
NPD1512 |
Approved |
0.8924 |
High Similarity |
NPD3882 |
Suspended |
0.8896 |
High Similarity |
NPD3818 |
Discontinued |
0.8889 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8875 |
High Similarity |
NPD5494 |
Approved |
0.8861 |
High Similarity |
NPD3817 |
Phase 2 |
0.8848 |
High Similarity |
NPD6797 |
Phase 2 |
0.8805 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8795 |
High Similarity |
NPD7251 |
Discontinued |
0.875 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD7075 |
Discontinued |
0.8743 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8743 |
High Similarity |
NPD7808 |
Phase 3 |
0.8679 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8645 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8625 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8618 |
High Similarity |
NPD1549 |
Phase 2 |
0.8614 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD5844 |
Phase 1 |
0.85 |
High Similarity |
NPD6801 |
Discontinued |
0.8487 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8476 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8447 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8438 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8424 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8383 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8294 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8246 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8228 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8221 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8158 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8158 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8158 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8144 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8133 |
Intermediate Similarity |
NPD919 |
Approved |
0.8107 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8052 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8039 |
Intermediate Similarity |
NPD943 |
Approved |
0.8037 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7961 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.795 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7947 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7925 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7911 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7857 |
Intermediate Similarity |
NPD3749 |
Approved |
0.784 |
Intermediate Similarity |
NPD2533 |
Approved |
0.784 |
Intermediate Similarity |
NPD2532 |
Approved |
0.784 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7836 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7753 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD920 |
Approved |
0.7735 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7702 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7701 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7684 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7673 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7673 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD6100 |
Approved |
0.765 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.765 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7643 |
Intermediate Similarity |
NPD447 |
Suspended |
0.764 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7622 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.761 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7607 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7595 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7579 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7571 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7561 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7557 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7548 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7546 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7545 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7542 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7542 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7532 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7529 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD37 |
Approved |
0.75 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7485 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7451 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7418 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7389 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7371 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7371 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7362 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7322 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.731 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7267 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7245 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7245 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD1203 |
Approved |
0.724 |
Intermediate Similarity |
NPD7698 |
Approved |
0.724 |
Intermediate Similarity |
NPD7697 |
Approved |
0.724 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7235 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7233 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7233 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7229 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7225 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7205 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7198 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7182 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7178 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7175 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7135 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7135 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7108 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7107 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7095
|
Intermediate Similarity |
NPD2403 |
Approved |